HPCAL1 and Alzheimer disease: VILIP3 is widespread in the brain (Bernstein et al. 1999), and previous studies have shown that the neuronal expression levels of VILIP3 are reduced in the cerebral cortex of patients with AD and that the abnormal location of VILIP3 correlates with typical neuropathological features of AD (Braunewell et al. 2001).